Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Hepatitis Diagnostic Tests Market?

In recent times, the market size for hepatitis diagnostic tests has seen a powerful surge. The growth is expected to rise from $4.64 billion in 2024 to $4.95 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.5%. Factors such as the globalization of healthcare, governmental actions, a high prevalence of diseases, enhanced blood safety protocols, and public health awareness campaigns are the driving forces behind the growth experienced during the historical period.

What Growth Rate Is Forecasted for the Hepatitis Diagnostic Tests Market by 2029?

The market size for hepatitis diagnostic tests is projected to witness significant expansion in the forthcoming years. The market is estimated to escalate to $6.24 billion by 2029, with a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period can be attributed to factors such as global health security issues, demographic growth and urbanization, customized testing strategies, focus on elimination programs, and increased healthcare expenditure. Leading trends within this period encompass enhancements in testing technologies, multiplex testing for various hepatitis viruses, incorporation of molecular diagnostics, digital health solutions, and strategical alliances and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13153&type=smp

Which Key Companies Are Shaping the Future of the Hepatitis Diagnostic Tests Market?

Major companies operating in the hepatitis diagnostic tests market report are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech PLC, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

Which Factors Are Driving Demand in the Hepatitis Diagnostic Tests Industry?

The increasing incidences of blood transfusions and donations are projected to spur the expansion of the hepatitis diagnostic test market. Both blood donations and transfusions interconnect in a practice where people voluntarily offer their blood which is then collected, tested, and given to patients needing extra blood components to cure ailments or to compensate for the blood loss incurred through surgeries, accidents, or sicknesses. Hepatitis diagnostic tests are critical in thoroughly scrutinizing blood before it is donated or transfused to ensure patients’ safety. For example, per the Royal College of Pathologists, a UK-based group, in August 2023, blood transfusion is the leading operation performed on hospitalized patients, with almost 2 million blood components exchanged and transfused in England yearly, amounting to more than £300 ($390.69) million. Consequently, the surge in blood transfusions and donations propels the hepatitis diagnostic test market.

Hepatitis Diagnostic Tests Market Driver: Growth in Hepatitis Diagnostic Tests Market Fueled by Hepatitis Incidence

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13153&type=smp

How Is the Hepatitis Diagnostic Tests Market Segmented by Several Divisions?

The hepatitis diagnostic tests market covered in this report is segmented –

1) By Test Type: Blood Tests, Imaging Tests, Liver Biopsy

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Test (INAAT), Other Technologies

3) By End User: Hospitals, Diagnostic Laboratories, Blood Bank, Other End Users

Subsegments:

1) By Blood Tests: Serological Tests, Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assays (ELISA)

2) By Imaging Tests: Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI)

3) By Liver Biopsy: Percutaneous Biopsy, Transjugular Biopsy, Laparoscopic Biopsy

What are the Emerging Market Trends Driving the Growth of the Hepatitis Diagnostic Tests Industry?

Key players in the hepatitis diagnostic test market are prioritizing the development of innovative automated immunoassays like Elecsys HCV Duo, to enhance their customer service. The Elecsys HCV Duo Automated immunoassays utilize automation systems and specialized equipment to execute all stages of the immunoassay process, including sample handling, reagent mixing, incubation, detection, and result computation. For instance, Roche Diagnostics India, a biotech research firm based in India, introduced Elecsys HCV Duo in July 2023. This product is the first of its kind commercially available fully automated immunoassay in India that facilitates the simultaneous and independent examination of hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum specimen. This system not only enables single specimen testing but also simplifies the diagnostic process, hence reducing the number of visits for additional tests and potentially easing the load on the healthcare system.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Which Regions Are Driving Growth in the Hepatitis Diagnostic Tests Market?

North America was the largest region in the hepatitis diagnostic tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13153

This Report Delivers Insight On:

1. How big is the hepatitis diagnostic tests market, and how is it changing globally?

2. Who are the major companies in the hepatitis diagnostic tests market, and how are they performing?

3. What are the key opportunities and risks in the hepatitis diagnostic tests market right now?

4. Which products or customer segments are growing the most in the hepatitis diagnostic tests market?

5. What factors are helping or slowing down the growth of the hepatitis diagnostic tests market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model